Herbas VPB

Print
EN | LT
LT - Diarilhidantoino junginiai, kaip androgeno receptorių antagonistai, skirti vėžio gydymui
EN - Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer

Legal status

Patent revoked (after opposition at EPO)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4184 (2006.01)
A61K 31/4166 (2006.01)
C07D 235/02 (2006.01)
C07D 233/86 (2006.01)
A61P 35/00 (2006.01)
C07D 401/04 (2006.01)
C07D 403/04 (2006.01)
C07D 403/10 (2006.01)
C07D 233/72 (2006.01)
C07D 233/84 (2006.01)
C07D 233/88 (2006.01)
European patent
(11) Number of the document 2444085
(13) Kind of document T
(96) European patent application number 11184401.5
Date of filing the European patent application 2006-03-29
(97) Date of publication of the European application 2012-04-25
(45) Date of publication and mention of the grant of the patent 2015-03-18
(46) Date of publication of the claims translation 2015-06-25
Priority applications
(30) Number Date Country code
680835 P 2005-05-13 US
750351 P 2005-12-15 US
756552 P 2006-01-06 US
Inventors
(72)
Sawyers, Charles L., US
Jung, Michael E., US
Chen, Charlie D., US
Ouk, Samedy, US
Welsbie, Derek, US
Tran, Chris, US
Wongpivat, John, US
Yoo, Dongwon, US
Grantee
(73) The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Diarilhidantoino junginiai, kaip androgeno receptorių antagonistai, skirti vėžio gydymui
  Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
Last renewal fee
Payment date Validity (years) Amount
2016-03-01 11 289.00 EUR
Legal status
Patent revoked (after opposition at EPO)
Invalidation date 2016-06-20